Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and Drug Utilization of Patients with Hereditary Angioedema in Italy, a Real-World Analysis.
Giacomini E, Leogrande M, Perrone V, Andretta M, Bacca M, Chinellato A, Ciaccia A, Cillo M, Lombardi R, Mancini D, Pagliaro R, Pastorello M, Procacci C, Degli Esposti L. Giacomini E, et al. Among authors: pastorello m. Healthcare (Basel). 2023 Sep 10;11(18):2509. doi: 10.3390/healthcare11182509. Healthcare (Basel). 2023. PMID: 37761706 Free PMC article.
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014.
Marcianò I, Ingrasciotta Y, Giorgianni F, Ientile V, Chinellato A, Tari DU, Gini R, Cannavò S, Pastorello M, Scondotto S, Cananzi P, Traversa G, Trotta F, Belleudi V, Addis A, Trifirò G. Marcianò I, et al. Among authors: pastorello m. Front Endocrinol (Lausanne). 2018 Mar 13;9:95. doi: 10.3389/fendo.2018.00095. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29593655 Free PMC article.
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents?
Ingrasciotta Y, Sultana J, Formica D, Ientile V, Aiello A, Chinellato A, Tari DU, Gini R, Pastorello M, Scondotto S, Cananzi P, Traversa G, Rossi M, Santoro D, Trifirò G; Italian Biosimilars Network (I-BioNetwork). Ingrasciotta Y, et al. Among authors: pastorello m. Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):65-77. doi: 10.1002/pds.5152. Epub 2020 Nov 16. Pharmacoepidemiol Drug Saf. 2021. PMID: 33067914
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy.
Ingrasciotta Y, Fontana A, Mancuso A, Ientile V, Sultana J, Uomo I, Pastorello M, Calabrò P, Andò G, Trifirò G. Ingrasciotta Y, et al. Among authors: pastorello m. Pharmaceuticals (Basel). 2021 Mar 25;14(4):290. doi: 10.3390/ph14040290. Pharmaceuticals (Basel). 2021. PMID: 33805899 Free PMC article.
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014.
Marcianò I, Ingrasciotta Y, Giorgianni F, Bolcato J, Chinellato A, Pirolo R, Di Giorgio A, Manna S, Ientile V, Gini R, Santarpia M, Genazzani AA, Uomo I, Pastorello M, Pollina Addario SW, Scondotto S, Cananzi P, Da Cas R, Traversa G, Rossi M, Sottosanti L, Caputi AP, Trifirò G. Marcianò I, et al. Among authors: pastorello m. BioDrugs. 2016 Aug;30(4):295-306. doi: 10.1007/s40259-016-0175-4. BioDrugs. 2016. PMID: 27138636
In Search of Predictors of Switching Between Erythropoiesis-Stimulating Agents in Clinical Practice: A Multi-Regional Cohort Study.
Ingrasciotta Y, Belleudi V, Trotta F, Addis A, Fontana A, Chinellato A, Ientile V, Tari DU, Roberto G, Pastorello M, Scondotto S, Cananzi P, Traversa G, Davoli M, Rossi M, Trifirò G; Italian Biosimilars Network (I-BioNetwork). Ingrasciotta Y, et al. Among authors: pastorello m. BioDrugs. 2020 Feb;34(1):55-64. doi: 10.1007/s40259-019-00385-y. BioDrugs. 2020. PMID: 31595485
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.
Ingrasciotta Y, Giorgianni F, Bolcato J, Chinellato A, Pirolo R, Tari DU, Troncone C, Fontana A, Ientile V, Gini R, Santoro D, Santarpia M, Genazzani A, Uomo I, Pastorello M, Addario WS, Scondotto S, Cananzi P, Caputi AP, Trifirò G. Ingrasciotta Y, et al. Among authors: pastorello m. BioDrugs. 2015 Aug;29(4):275-84. doi: 10.1007/s40259-015-0132-7. BioDrugs. 2015. PMID: 26169209 Free PMC article.
Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.
Ingrasciotta Y, Bertuccio MP, Crisafulli S, Ientile V, Muscianisi M, L'Abbate L, Pastorello M, Provenzano V, Scorsone A, Scondotto S, Trifirò G. Ingrasciotta Y, et al. Among authors: pastorello m. Int J Environ Res Public Health. 2020 Dec 18;17(24):9514. doi: 10.3390/ijerph17249514. Int J Environ Res Public Health. 2020. PMID: 33353081 Free PMC article.
52 results